Decoding the molecular landscape: HER2 and PD-L1 in advanced gastric cancer
IntroductionEpidermal growth factor receptor 2 (HER2) and programmed cell death ligand 1 (PD-L1) are pivotal therapeutic targets for advanced gastric cancer (GC). Nevertheless, the correlation between them, along with the clinical and genomic characteristics and prognosis differences across distinct...
Saved in:
| Main Authors: | Jun Yao, Qiang Sun, Han Wu, Xiaokai Zhao, Pengmin Yang, Xiaozhi Wang, Xintao Wang, Meiping Gu, Jieyi Li, Yuansi Zheng, Ziying Gong, Daoyun Zhang, Weijun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1567308/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Automated interpretation of PD-L1 CPS based on multi-AI models integration strategy in gastric cancer
by: Ting Han, et al.
Published: (2025-08-01) -
Carnosic acid enhances cisplatin sensitivity and suppresses gastric cancer progression via the TP53/SLC7A11/ALOX12 axis
by: Li Zhou, et al.
Published: (2025-07-01) -
Survival of patients with salivary gland malignancies depending on the molecular profile of the tumor
by: S. I. Kutukova, et al.
Published: (2020-11-01) -
Relationship between programmed cell death ligand 1 expression and the number of biopsy specimens in advanced gastric cancer
by: Taro Mizuno, et al.
Published: (2025-07-01) -
LSD1 is a targetable vulnerability in gastric cancer harboring TP53 frameshift mutations
by: Suzeng Wang, et al.
Published: (2025-02-01)